Inhaled sedation in the intensive care unit: what's the future for AnaConDa (TM)?

被引:0
作者
L'Her, E. [1 ]
机构
[1] Univ Bretagne Occidentale, CHRU Cavale Blanche, Reanimat Med & Urgences Adultes, F-29609 Brest, France
来源
REANIMATION | 2014年 / 23卷 / 01期
关键词
Sedation; Intensive care; Halogenated agents; Isoflurane; Sevoflurane;
D O I
10.1007/s13546-013-0833-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sedation contributes to patient's comfort and plays an essential role in the intensive care unit (ICU). Several clinical studies have reported the occasional use of volatile halogenated agents in the ICU; however, long-term use is possible in routine for the provision of a dedicated evaporator filter (AnaConDa (TM)[ACD]). Because of their low cost and pharmacological characteristics with a rapid therapeutic effect, a high therapeutic index, a possible use regardless of age and underlying medical conditions, and a good knowledge of their adverse effects, halogenated agents could be considered like possible ideal anesthetic agents in the ICU. The objective of this technical note is to clarify the potential indications of ACD device and describe its operative principles and potential drawbacks.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 50 条
  • [21] Desflurane compared with propofol for postoperative sedation in the intensive care unit
    Meiser, A
    Sirtl, C
    Bellgardt, M
    Lohmann, S
    Garthoff, A
    Kaiser, J
    Hügler, P
    Laubenthal, HJ
    BRITISH JOURNAL OF ANAESTHESIA, 2003, 90 (03) : 273 - 280
  • [22] Economic evaluation of sustained sedation/analgesia in the intensive care unit
    MacLaren, Robert
    Sullivan, Patrick W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (15) : 2047 - 2068
  • [23] Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa®: effects on cerebral oxygenation, circulation, and pressure
    Julian Bösel
    Jan C. Purrucker
    Frank Nowak
    Julian Renzland
    Petra Schiller
    Eva Benveniste Pérez
    Sven Poli
    Benjamin Brunn
    Werner Hacke
    Thorsten Steiner
    Intensive Care Medicine, 2012, 38 : 1955 - 1964
  • [24] Safety and Effectiveness of Sedation With Adjunctive Ketamine Versus Nonketamine Sedation in the Medical Intensive Care Unit
    Jaeger, Melanie
    Attridge, Rebecca L.
    Neff, Luke A.
    Gutierrez, G. Christina
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (06) : 850 - 856
  • [25] Toward less sedation in the intensive care unit: A prospective observational study
    Salgado, Diamantino R.
    Favory, Raphael
    Goulart, Mateus
    Brimioulle, Serge
    Vincent, Jean-Louis
    JOURNAL OF CRITICAL CARE, 2011, 26 (02) : 113 - 121
  • [26] Consensus guidelines on analgesia and sedation in dying intensive care unit patients
    Laura A Hawryluck
    William RC Harvey
    Louise Lemieux-Charles
    Peter A Singer
    BMC Medical Ethics, 3 (1)
  • [27] Communication of sedation in the intensive care unit: Is it the real issue?
    Ramelet, Anne-Sylvie
    CRITICAL CARE MEDICINE, 2010, 38 (08) : 1748 - 1749
  • [28] Sedation Options for Intubated Intensive Care Unit Patients
    Lacoske, Jennifer
    CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2015, 27 (01) : 131 - +
  • [29] Pharmacological sedation management in the paediatric intensive care unit
    Baarslag, Manuel A.
    Allegaert, Karel
    Knibbe, Catherijne A. J.
    van Dijk, Monique
    Tibboel, Dick
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 (05) : 498 - 513
  • [30] AnaConDa™ and Mirus™ for intensive care sedation, 24 h desflurane versus isoflurane in one patient
    Bomberg, Hagen
    Groesdonk, Heinrich V.
    Bellgardt, Martin
    Volk, Thomas
    Meiser, Andreas
    SPRINGERPLUS, 2016, 5